Swiss dentists Drs Haley and Goly Abivardi are the world over famend inno vators, award-winning marketers, and the CEOs and founders of vVARDIS, a pioneering Swiss producer of oral care and whitening merchandise. On the Global Dental Display (IDS) 2025, the Abivardi sisters spoke about their groundbreaking product, Curodont Restore.
Prevention has at all times been on the middle of vVARDIS’s philosophy. How are your newest merchandise serving to to shift dentistry additional in opposition to prevention fairly than recovery?
Dr Haley Abivardi: Curodont Restore is our hero product. It’s the primary drugs that may deal with early decay. It’s greater than prevention; it’s recovery, the place the enamel makes its personal filling. Roughly 80 % of sufferers sitting within the dental chair have early decay. At the same time as dental scholars, we realized that early decay had no remedy; we’d merely have to observe it and hope the affected person returned in time. Drilling takes away an excessive amount of wholesome enamel construction. Dentists have at all times felt uneasy about this. Now, dentists or dental hygienists can deal with early cavities in 5 mins, liberating up chair time. It’s a win–win for everybody!
Dr Goly Abivardi: It’s the first product to allow regeneration of teeth, and that is modern! It lets in dentists to regard early indicators of cavities non-invasively. In medication, we’ve finished this for years—treating early indicators of illness instantly—however in dentistry, this wasn’t imaginable till now. We’re introducing a brand new technology in dentistry. For us, prevention, early intervention and accessibility have at all times been the focal point. We consider that our product could have a super have an effect on on sufferers and dentists. As dental pros, we would like the most productive for our sufferers.
We now have over 25 years of clinical analysis in the back of this era. Over the past decade, masses of 1000’s of sufferers had been handled effectively in the United States and Europe—with out a uncomfortable side effects. Universities at the moment are together with this era of their curricula. It’s changing into the brand new same old of care—a fully new class.
Present merchandise act tremendous ficially. Our product penetrates deeply into lesions, development a matrix that pulls minerals from the saliva in order that calcium and phosphate will also be crystalised into hydroxyapatite. The enamel successfully builds its personal filling from minerals within the saliva. It’s biomimetic era, harnessing herbal
processes.
Dr Haley Abivardi: We’re reaching what was once thought to be unimaginable: regenerating teeth. The enamel is restored to its herbal state.
Dr Goly Abivardi: It’s really useful for everybody. Sufferers respect non-invasive remedy; dentists see stepped forward affected person retention. Moreover, it generates new earnings for dental practices.
For the reason that closing IDS, vVARDIS has partnered with OrbiMed to protected considerable financing. What have an effect on has this partnership had in your strategic path?
Dr Haley Abivardi: OrbiMed is very revered in pharma, making an investment solely in world-class healthcare corporations that deal with unmet scientific wishes. It’s the primary time that it has invested in dentistry, as a result of our product addresses the arena’s main non-communicable illness.
How have dental pros’ attitudes in opposition to non-invasive therapies modified over contemporary years, in particular because you offered your era?
Dr Goly Abivardi: Dentistry is moving in opposition to prevention and noninvasive approaches, making this the easiest time for Curodont. Sufferers too now perceive the significance of early intervention.
Dr Haley Abivardi: Consciousness of the hyperlink between oral and general well being has greater considerably. A couple of years in the past, the International Well being Group handed a decision recognising oral well being as integral to common well being, emphasising the mouth because the gateway to the frame.
What’s your imaginative and prescient for the way forward for non-invasive dentistry?
Dr Haley Abivardi: Our purpose is to make Curodont available to everybody in every single place. In the United States, we offered it early closing 12 months, and Curodont is already in just about 10% of dental places of work within the nation. It’s impulsively rising. We’re seeing an overly excessive acceptance fee amongst sufferers. Our product is to be had already in the United States, Europe and within the Emirates.
Tags:
Reside webinar
Tue. 1 April 2025
12:00 pm EST (New York)
Dr. Christian Jarry
Reside webinar
Wed. 2 April 2025
11:00 am EST (New York)

Kostia Vyshamirski
Reside webinar
Wed. 2 April 2025
12:30 pm EST (New York)
Adriana Forino CRDH
Reside webinar
Thu. 3 April 2025
6:00 pm EST (New York)
Dr. Jorge Noriega
Reside webinar
Thu. 3 April 2025
8:00 pm EST (New York)
Dr. Parul Dua Makkar BSc, DDS, FACD
Reside webinar
Tue. 8 April 2025
7:00 pm EST (New York)
Prof. Dr. Wael Att, Dr. Robert A. Levine DDS, FCPP, FISPPS, AOD
Reside webinar
Wed. 9 April 2025
2:00 pm EST (New York)

Prof. Hani Ounsi DDS PhD FICD
:sharpen(level=0):output(format=jpeg)/up/dt/2025/03/Drs-Haley-and-Goly-Abivardi-of-vVARDIS..jpg?w=750&resize=750,375&ssl=1)


:sharpen(level=0):output(format=jpeg)/up/dt/2025/03/Revolutionising-3D-printing-with-artificial-intelligence-c-Vasyl-RohanShutterstock.jpg?w=120&resize=120,86&ssl=1)